Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
doi:10.1136/bmjdrc-2016-000258
Your clinician will guide dosing, timing, and safety screening
Conflict of Interests The authors have no competing interests to declare that are relevant to the content of this article
You want flat-rate, all-in pricing without a membership tier
Its important to note that the dosing calendar above is based on a typical titration path, but this will look different for everyone
For Medicare Part D, this model will be implemented in January 2027, following a separate short-term demonstration that will allow Medicare Part D enrollees to access obesity drugs beginning in July 2026
US$ 22.67
US$ 26.92
US$ 23.82
US$ 22.44
US$ 23.57
